IPPTO is a new PhD excellence program supported by the Austrian Science Fund’s doc.funds initiative. IPPTO operates within the framework of the Medical University of Vienna’s graduate training program providing cutting-edge education in all fields of cancer research.

2 PhD positions in translational oncology at the Medical University of Vienna

The Medical University of Vienna announces 2 PhD positions in the field of Translational Cancer Research, with a special focus on therapy resistance in cancer.
The overall scientific aim of the International PhD Program in Translational Oncology (IPPTO) is to better understand mechanisms shaping anticancer therapy responses, design strategies to better stratify patients, and to identify potential strategies that delay or impair therapy resistance.

1. "Role of CXCL5 in the plasticity and progression of hepatocellular carcinoma"
   Laboratory of Wolfgang Mikulits
2. "Targeting Drug-Tolerant Persisters: A Paradigm Shift in Combating Therapy-Resistant Breast Cancer"
   Laboratory of Gergely Szakacs

Requirements for a complete application:

• Completed application form (download here)
• Curriculum vitae
• Completed master's degree
• Diploma
• Two letters of reference

Please send your complete application to ippto@meduniwien.ac.at

Registration deadline: November 30, 2020